血清脂肪酶水平与慢性肾病临床分型和分期相关性研究

Correlation of serum lipase with chronic nephrology clinical classification and chronic kidney disease stages

  • 摘要: 目的 探讨血清脂肪酶(LPS)在慢性肾脏疾病患者血清中表达的变化。方法 140例慢性肾脏病患者,入选标准:1)原发性慢性肾脏病;2)排除肿瘤、系统性红斑狼疮、急/慢性胰腺炎;3)年龄小于70岁;4)药物治疗前。健康对照为当天健康人血清样本60例,测定LPS水平,并计算肾小球滤过率(GFR)。根据临床诊断分为肾病综合征组(NS)、慢性肾炎综合征组(CNS);根据慢性肾脏病(CKD)分级分为CKD1组、CKD2-3组、CKD4-5组及透析组。进行相关性统计分析。结果 健康组、CNS组、NS组的CKD1组、CKD2-3组、CKD4-5组、透析组血清LPS水平分别为78.55U/L、194.05U/L、163.04U/L,140.72U/L、158.25U/L、314.53U/L、322.13U/L,均与健康组有显著差异(P<0.01);CKD1、CKD2-3与CKD4-5组/透析组均有统计学差异(P<0.01,P<0.05,P<0.01)。LPS与GFR、血清肌酐具有相关性(P<0.05,P<0.01)。结论 当慢性肾脏病患者有明显的临床表现时(肾病综合征或慢性肾...

     

    Abstract: Objective To study the change of lipase(LPS) expression in patients with chronic kidney disease(CKD). Methods One hundred patients and 60 healthy controls were enrolled in this study.Correlation of serum LPS levels with CKD was studied in 140 CKD patients.Those who had primary CKD but no tumors,systemic lupus erythematosus,acute or chronic pancreatitis,and did not receive drug treatment,with their age less than 70 years,were included in the study.Serum LPS levels in patients and controls were measured.Glomerular filtration rate of patients was calculated.The patients were divided into nephritic syndrome(NS) group and chronic nephritic syndrome(CNS) group according to their clinical diagnosis,and into CKD1,CKD2-3,and CKD4-5 dialysis groups according to their CKD stages.Statistical analysis was performed using the CHISS software. Results The serum LPS level was 78.55U/L and 194.05U/L in control group and CNS group,respectively,and 163.04U/L,140.72U/L,158.25U/L,314.53U/L and 322.13U/L in CKD1 dialysis group,CKD2-3 dialysis group,and CKD4-5 dialysis group,respectively(P<0.01).Serum LPS level was correlated with GFR and serum creatinine(SCr)(P<0.05,P<0.01).The coefficients were-0.232 and 0.276. Conclusion Serum LPS level is elevated in CKD patients,and is correlated with SCr and GFR.Serum LPS level tends to increase through the progression of CKD.

     

/

返回文章
返回